Pooja Khandelwal is an Oncology physician affiliated with Cincinnati Children's Hospital Medical Center. OpenAlex indexes 155 publications with 1,504 citations (h-index 20); ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Upfront Ruxolitinib for Chronic Graft-vs-host Disease
Sponsor: Children's Hospital Medical Center, Cincinnati
- Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
Sponsor: Children's Hospital Medical Center, Cincinnati
- Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD
Sponsor: Incyte Corporation
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Incyte CorporationProgram year20252 payments$18,883openpaymentsdata.cms.gov ↗
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20259 payments$12,428openpaymentsdata.cms.gov ↗
- Mesoblast, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Use of Teduglutide in the Management of Gastrointestinal Graft-versus-Host Disease in Children and Young Adults
Biology of Blood and Marrow Transplantation
2024 - Topical ruxolitinib is promising as sole or adjunctive therapy in treating maculopapular rash of acute and chronic skin GVHD
Bone Marrow Transplantation
2024 - Ruxolitinib Pharmacokinetics and Pharmacodynamics in Children with Acute and Chronic Graft-versus-Host Disease
Biology of Blood and Marrow Transplantation
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Andrea Beaton, MD
Cincinnati Children's Hospital Medical Center
Prasad Devarajan, MD
Cincinnati Children's Hospital Medical Center
Stuart Goldstein, MD
Cincinnati Children's Hospital Medical Center
Tracy Glauser, MD
Cincinnati Children's Hospital Medical Center
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”